研究员,临床前病理/Research Investigator, Pathology Research(博士)当面告知
百濟神州有限公司
2026-12-15 15:28:34
校招博士27届硕士
岗位详情
地区:
北京
·
上海
专业要求:
专业不限
岗位职责:
We are seeking a pathologist to join the in vivo pharmacology team to support programs in preclinical and clinical development stages. The individual will bring pathology expertise with hands-on approaches to guide preclinical decisions and assist with decision making as programs move to clinical trials. The individual will help to optimize the histology and toxicology approaches, design studies and move the programs forward using high-quality tissue-based assays and data analysis. The individual will work cross-functionally with the project teams across a broad spectrum of portfolios including but not limited to Tumor Biology, Immuno-oncology and Non-oncology programs.
Responsibility
Build, organize and operate a translational pathology laboratory
Being a vital member of the team to develop and optimize pathology methods for drug R&D. This includes, but not limited to, techniques used for molecular pathology, histology, investigative pathology/toxicology
Drive high quality data analysis relevant to pathology and manage data generated both internally and externally
Build a state-of-the-art pathology technology platform, including but not limited to, methods of IHC, IF and ISH to support characterization of established and novel targets.
Guide pathology and imaging decision making with teams as drug candidates approach clinical stages
Provide expert guidance on pathology and other tissue-based assays for cross functional research and development teams as needed
Contribute to the implementation of pathology laboratory information & data management system
Comply with regulated laboratory standards for pathology and IHC documentation and reporting standards
Contribute to IND/NDA/CTA filing as the pharmacology/toxicology section author
Requirements
Position will be hired based on level of experience
Master or Ph.D. degree in molecular biology, cancer biology, pathology or related fields
Proven record of relevant experience and expertise in toxicology pathology or translational pathology work in drug discovery and/or development settings
Hands-on experience with a wide array of anatomic pathology laboratory platforms (e.g., histology, IHC/ISH/IF/multiplexing, light/fluorescent/confocal microscopy, digital pathology image analysis) across fresh frozen and paraffin-embedded formats
Experienced in assay development and optimization, and trouble-shooting of IHC/ISH/multiplexing assays and image analysis
Previous exposure to IND/CTA filing is a plus
Self-starter attitude, excellent interpersonal skills and comfortable in a fast pace biotech environment
招聘要求:
We are seeking a pathologist to join the in vivo pharmacology team to support programs in preclinical and clinical development stages. The individual will bring pathology expertise with hands-on approaches to guide preclinical decisions and assist with decision making as programs move to clinical trials. The individual will help to optimize the histology and toxicology approaches, design studies and move the programs forward using high-quality tissue-based assays and data analysis. The individual will work cross-functionally with the project teams across a broad spectrum of portfolios including but not limited to Tumor Biology, Immuno-oncology and Non-oncology programs.
Responsibility
Build, organize and operate a translational pathology laboratory
Being a vital member of the team to develop and optimize pathology methods for drug R&D. This includes, but not limited to, techniques used for molecular pathology, histology, investigative pathology/toxicology
Drive high quality data analysis relevant to pathology and manage data generated both internally and externally
Build a state-of-the-art pathology technology platform, including but not limited to, methods of IHC, IF and ISH to support characterization of established and novel targets.
Guide pathology and imaging decision making with teams as drug candidates approach clinical stages
Provide expert guidance on pathology and other tissue-based assays for cross functional research and development teams as needed
Contribute to the implementation of pathology laboratory information & data management system
Comply with regulated laboratory standards for pathology and IHC documentation and reporting standards
Contribute to IND/NDA/CTA filing as the pharmacology/toxicology section author
Requirements
Position will be hired based on level of experience
Master or Ph.D. degree in molecular biology, cancer biology, pathology or related fields
Proven record of relevant experience and expertise in toxicology pathology or translational pathology work in drug discovery and/or development settings
Hands-on experience with a wide array of anatomic pathology laboratory platforms (e.g., histology, IHC/ISH/IF/multiplexing, light/fluorescent/confocal microscopy, digital pathology image analysis) across fresh frozen and paraffin-embedded formats
Experienced in assay development and optimization, and trouble-shooting of IHC/ISH/multiplexing assays and image analysis
Previous exposure to IND/CTA filing is a plus
Self-starter attitude, excellent interpersonal skills and comfortable in a fast pace biotech environment
公司介绍

百濟神州有限公司
百濟神州有限公司,成立于2018-06-28,位于香港,登记状态:仍注册,注册资本15.4142万美元,公司类型:中外合资
百济神州有限公司是一家商业化阶段的生物技术公司,专注于开发及商业化用于治疗癌症的创新型分子靶向及肿瘤免疫治疗药物。百济神州拥有广泛全面的产品组合。其产品包括六种内部开发、临床阶段的候选药物,其中包括三种后期临床候选药物,zanubrutinib(BTK抑制剂),tislelizumab(PD-1抗体)与pamiparib(PARP抑制剂)。百济神州亦获得五种药物及在研药物的授权许可,包括三种已于中国销售的由新基独家授权的药物ABRAXANE、REVLIMID 及VIDAZA,及两种临床阶段的在研药物,该种药物已获得于中国及亚太地区的其他指定国家开发及商业化的权利。百济神州于2010年于北京成立并在2016年2月在美国纳斯达克全球精选市场上市。截至2018年7月,公司拥有一支超过1300名员工的全球团队,成为一家拥有涵盖研究、临床开发、生产及商业化的全面实力的全球生物技术公司。